Skip to content

CRISPR Therapeutics CRSP FX Effect on Cash

FX Effect on Cash at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$997K+348%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
-$1.33M-878%
Revvity logo
RevvityRVTY
-$7.63M-147%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$900K-250%
Incyte logo
IncyteINCY
-$2.69M-387%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$1.52M-128%

Other financials

Income statement

See full
Revenue$1.5M+68.6%
Operating income-$130.2M+12.2%
Net income-$122.9M+9.6%
EPS (diluted)-$1.28+19.0%

Balance sheet

See full
Cash & equivalents$423.3M+80.0%
Total debt$787.6M+259%
Total equity$1.8B-0.8%
Total assets$2.7B+25.8%

Cash flow

See full
Operating cash flow-$108.9M-102%
CapEx$504.0K+145%
Free cash flow-$109.4M-102%

Valuation

See full
Market cap$5.33B+56.4%
Enterprise value$5.69B+69.8%
P/S1,298.3×+1,208×

Profitability

See full
Operating margin-15,754.2%-17,253pp
Net margin-13,856.5%-15,058pp
FCF margin-9,777.6%-10,759pp

Returns & leverage

See full
Return on equity-31.2%+43.7pp
Debt / equity0.4×+0.3×
Current ratio18×+2.3×

Where this comes from

Reported directly by CRISPR Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CRISPR Therapeutics's FX effect on cash?
CRISPR Therapeutics (CRSP) reported FX effect on cash of -$32K in Q1 2026.
How has CRISPR Therapeutics's FX effect on cash changed year-over-year?
CRISPR Therapeutics's FX effect on cash decreased by 178.0% year-over-year, from $41K to -$32K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.